FITC anti-mouse CD45.1 Antibody

Pricing & Availability
Clone
A20 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5.1, LCA
Isotype
Mouse (A.SW) IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
A20_FITC_090507
SJL mouse splenocytes stained with A20 FITC
  • A20_FITC_090507
    SJL mouse splenocytes stained with A20 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
110705 50 µg £41
Check Availability


Need larger quantities of this item?
Request Bulk Quote
110706 500 µg £76
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45.1 is an alloantigen of CD45, expressed by Ly5.1 bearing mouse strains (e.g., RIII, SJL/J, STS/A, DA). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in mice that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell types. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
SJL mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The A20 antibody does not react with leukocytes or mouse cells expressing the CD45.2 alloantigen. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation3, in vitro blocking of B cell responses1,2, immunohistochemical staining of frozen sections: OCT embedded7 and acetone-fixed4-6 (direct immunofluorescence detection with fluorochrome conjugated A20 was used in (5) and (6)).

Application References

(PubMed link indicates BioLegend citation)
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  4. Suzuki K, et al. 2000. Immunity 13:691. (IHC-F)
  5. Werner N, et al. 2002. Arterioscler. Thromb. Vasc. Biol. 22:1567. (IHC-F)
  6. Lessner SM, et al. 2002. Am. J. Pathol. 160:2145. (FC, IHC-F)
  7. Chen CC, et al. 2005. P. Natl. Acad. Sci. USA 102:11408 (IHC-F)
  8. Pascal V, et al. 2007. J. Immunol. 179:1751. (FC)
  9. Mende I, et al. 2006. Blood 107:1383. (IHC-F, FC)
  10. Phan TG, et al. 2007. Nature Immunol. 8:992. (FC)
  11. Wither DR, et al. 2009. J. Immunol. 183:5079. PubMed
  12. Pascal V, et al.2007. J. Immunol. 179:1751. PubMed
  13. Lee SW, et al. 2009. J. Immunol. 182:6753. PubMed
  14. Takada K, et al. 2009. J. Exp Med. 206:2253. PubMed
  15. Beamer CA, et al. 2007. Am. J. Respir. Cell. Mol. Biol. 37:729. (FC) PubMed
  16. Li LX, et al. 2010. J. Immunol. 184:1728. PubMed
  17. Hosoi A, et al. 2008. Cancer Res. 68:3941. (FC) PubMed
  18. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  19. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  2. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  3. Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed
  4. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  5. Vasanthakumar A, et al. 2020. Nature. 579:581. PubMed
  6. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  7. Weulersse M, et al. 2020. Immunity. 53(4):824-839.e10. PubMed
  8. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  9. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  10. Baryawno N et al. 2019. Cell. 177(7):1915-1932 . PubMed
  11. Degn SE et al. 2017. Cell. 170(5):913-926 . PubMed
  12. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  13. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  14. Stewart I et al. 2018. Immunity. 49(3):477-489 . PubMed
  15. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  16. Chen S, et al. 2022. Cancer Discov. :. PubMed
  17. Hess NJ, et al. 2020. J Immunol. 205:272. PubMed
  18. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  19. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  20. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  21. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  22. Bonnet C, et al. 2021. iScience. 24:103399. PubMed
  23. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  24. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  25. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  26. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  27. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  28. Yang F, et al. 2020. Cancer Res. 80:3677. PubMed
  29. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  30. Yoshimi A, et al. 2019. Nature. 574:273. PubMed
  31. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  32. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  33. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  34. Sandrock I, et al. 2015. PLoS One. 10: 0145010. PubMed
  35. Flommersfeld S, et al. 2021. Immunity. :. PubMed
  36. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  37. He L, et al. 2019. iScience. 0.790972222. PubMed
  38. Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
  39. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  40. Kinkel SA, et al. 2022. iScience. 25:104684. PubMed
  41. Fan Z, et al. 2020. EMBO Mol Med. 12:e11571. PubMed
  42. Ise W, et al. 2018. Immunity. 48:702. PubMed
  43. Lee S, et al. 2009. J Immunol. 182:6753. PubMed
  44. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  45. Schepanski S, et al. 2022. Nat Commun. 13:4571. PubMed
  46. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  47. Lee P, et al. 2014. J Immunol. 192:178. PubMed
  48. Wan X, et al. 2018. Nature. 560:107. PubMed
  49. Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed
  50. Xu X, et al. 2018. Cell. 175:1336. PubMed
  51. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  52. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  53. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  54. Qin Q, et al. 2021. Cell Reports. 35(8):109161. PubMed
  55. Chatterjee D, et al. 2021. Cell Reports. 35(2):108996. PubMed
  56. Murakami K, et al. 2021. Cell Reports. 34(1):108579. PubMed
  57. Jameson K 2009. J Exp Med. 206:2253. PubMed
  58. Shin JJ, et al. 2020. Cell Rep. 32:108093. PubMed
  59. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  60. Port JR, et al. 2020. J Virol. 94:. PubMed
  61. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  62. Kretschmer L, et al. 2020. Nat Commun. 0.536805556. PubMed
  63. Wu B, et al. 2021. Immunity. 54(2):308-323.e6. PubMed
  64. Fallet B, et al. 2016. Immunology. 1: eaah6817. PubMed
  65. Hata T, et al. 2013. J Immunol. 191:83. PubMed
  66. Firl DJ et al. 2018. eLife. 7 pii: e33051. PubMed
  67. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  68. Stephens WZ, et al. 2021. Cell Rep. 37:109916. PubMed
  69. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  70. Ulland T, et al. 2016. Nat Commun. 7:13180. PubMed
  71. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  72. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  73. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  74. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  75. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  76. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  77. Muri J, et al. 2020. Cell Reports. 29(9):2731-2744.e4.. PubMed
  78. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  79. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  80. Wu G, et al. 2021. Nat Cancer. 2:1170. PubMed
  81. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  82. Ikeda T, et al. 2014. PLoS One. 9:115198. PubMed
  83. Gundra UM, et al. 2017. Nat Immunol. 1.195833333. PubMed
  84. Wu B, et al. 2022. Nat Commun. 13:2155. PubMed
  85. Tanaka S, et al. 2021. Am J Transplant. 21:353. PubMed
  86. Alam IS, et al. 2020. Cancer Res. 80:4780. PubMed
  87. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  88. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  89. Huang L, et al. 2015. PLoS Pathog. 11: 1005347. PubMed
  90. Vannini N, et al. 2016. Nat Commun. 7:13125. PubMed
  91. Alterauge D, et al. 2020. Cell Rep. 33:108232. PubMed
  92. Hall JA, et al. 2020. Cell Metabolism. 32(4):665-675.e6. PubMed
  93. Young K, et al. 2021. Cell Stem Cell. . PubMed
  94. Gay L, et al. 2013. Genes Dev. 27:98. PubMed
  95. Cabal-Hierro L, et al. 2020. Nat Commun. 11:1406. PubMed
  96. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  97. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  98. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  99. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  100. Chang MH, et al. 2021. Cell Rep. 37:109902. PubMed
RRID
AB_313494 (BioLegend Cat. No. 110705)
AB_313495 (BioLegend Cat. No. 110706)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.1 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.1 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Biotin anti-mouse CD45.1

  • FITC anti-mouse CD45.1

  • PE anti-mouse CD45.1

  • Purified anti-mouse CD45.1

  • APC anti-mouse CD45.1

  • APC/Cyanine7 anti-mouse CD45.1

  • Alexa Fluor® 488 anti-mouse CD45.1

  • Alexa Fluor® 647 anti-mouse CD45.1

  • Pacific Blue™ anti-mouse CD45.1

  • Alexa Fluor® 700 anti-mouse CD45.1

  • Brilliant Violet 650™ anti-mouse CD45.1

  • PerCP anti-mouse CD45.1

  • PerCP/Cyanine5.5 anti-mouse CD45.1

  • PE/Cyanine7 anti-mouse CD45.1

  • Brilliant Violet 421™ anti-mouse CD45.1

  • Brilliant Violet 570™ anti-mouse CD45.1

  • Brilliant Violet 605™ anti-mouse CD45.1

  • Brilliant Violet 711™ anti-mouse CD45.1

  • Brilliant Violet 510™ anti-mouse CD45.1

  • Brilliant Violet 785™ anti-mouse CD45.1

  • Purified anti-mouse CD45.1 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse CD45.1

  • Alexa Fluor® 594 anti-mouse CD45.1

  • APC/Fire™ 750 anti-mouse CD45.1

  • TotalSeq™-A0178 anti-mouse CD45.1

  • TotalSeq™-B0178 anti-mouse CD45.1

  • TotalSeq™-C0178 anti-mouse CD45.1

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account